Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the ‘quality-of-life’ of the affected patient populace. The Neuroprosthetics, as therapeutic modalities, are emerging as a promising option in cases where all conventional treatments fail to deliver results/treatment to the disease condition. Improvement in the ‘quality-of-life’ of the affected patients, high availability of funds for R&D of Neuroprosthetics from the Government (public) and private sector investments in turn aid development of newer and improved variants of Neuroprosthetics - all result in increased uptake by the patients. Thus, the afore-mentioned are key drivers of the Neuroprosthetics market; however, reimbursement issues and high cost of Neuroprosthetics/devices are the restraints to the market growth. Owing to the high-impact growth drivers that outweigh the restraints, the global neuroprosthetics market is forecast to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.
The global neuroprosthetics market is segmented based on technology, types, applications and geography. The Neuroprosthetics’ Mechanism Of Action (MOA) varies as per underlying technology; hence, Neuroprosthetics can also be classified by technology into - Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS) and Sacral Nerve Stimulation (SCS). Various types of Neuroprosthetics have been developed based on the application areas, i.e., the disease condition treated, for example, Motor Neuroprosthetics ‐ treat motor neuron disorders such as Parkinson’s disease, Epilepsy, Auditory Neuroprosthetics/ Cochlear implants ‐ treat hearing disorders; Visual Neuroprosthetics/ Retinal implants ‐ treat visual impairment; and Cognitive Neuroprosthetics - treat Alzheimer’s disease, and severe depression. Visual Neuroprosthetics/ Retinal implants, is the fastest growing (CAGR 31.5%) Neuroprosthetics segment, owing to high-impact growth attribute of improving ‘quality-of-life’ of visually impaired patients. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.
Developing bio-compatible, sensitive and safe products are the keys to success in the global Neuroprosthetics market. In tune with this, many companies across the world are involved in the R&D of newer and multitude of variants of Neuroprosthetics’ product lines and is seeking regulatory approval and commercialization. Few of such companies are profiled in the report - Medtronic Inc., MED-EL, Advanced Bionics AG, Boston Scientific Corporation, Biomet, Inc., St. Jude Medical, Retina Implant AG, NeuroPace, Inc. and NDI Medical LLC.
The global neuroprosthetics market is segmented according to / by - technology, type, application, and geography.
MARKET BY TECHNOLOGY
MARKET BY TYPE
MARKET BY APPLICATION
MARKET BY GEOGRAPHY
The Global Vegetarian Softgel Capsules market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Vegetarian Softgel Capsules market, especially in North America, Europe, Asia-Pacific, South ...
October 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetarian Softgel Capsules in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
October 2017 | $4660 |View Details>>
In 2016, the Vegetarian Softgel Capsules market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Catalent Procaps Laboratorios ...
October 2017 | $3360 |View Details>>
In 2016, the Europe Vegetarian Softgel Capsules market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Vegetarian Softgel Capsules in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other ...
October 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research